Meeting Program

The meeting program begins on Thursday, January 30 at 12:00 and ends on Saturday, February 1 at 16:45. 
Please visit this page regularly for the most up to date program. 

Day 1, Thursday, January 30

12:00 - 12:15 Opening Ceremony

  • Opening & Welcome
    H Einsele & C Chabannon (Chairs of the Scientific Program Committee)
  • About EHA/EBMT and their activities
    J Gribben (President EHA) & N Kröger (President EBMT)

12:15 - 12:45 Keynote Lecture

  • Informed design of engineered T cell therapies for cancer
    S Riddell (United States)

12:45 - 14:15 Indications for CAR T Cell therapy

  • Acute leukemia
    A Nagler (Israel)
  • Multiple myeloma
    H Einsele (Germany)
  • Lymphoma
    C Thieblemont (France)

14:15 - 15:15 Improving the efficacy and safety profile

  • Targeted genomic insertion
    D Busch (Germany)
  • Virus-free gene transfer & genome editing
    Z Ivics (Germany)
  • In vivo transduction
    Speaker to be announced

15:15 - 15:45 Coffee break & Industry theater session

15:45 - 16:15 Keynote lecture

  •  C MacKall (United States)

16:15 - 17:15 CAR T in pediatrics

  • Post transplant relapse-Second SCT or CAR T-cells
    P Bader (Germany)
  • Neuroblastoma
    F Locatelli (Italy) 
  • Bispecific CAR T Cells
    P Amrolia (United Kingdom)

17:15 - 17:45  Keynote Lecture

  • M Pule (United Kingdom)

17:45 - 18:45 Best Abstracts & Flash Talks - Part I

Chairs: H Einsele & C Chabannon (Chairs of the Scientific Program Committee)

19:00 - 19:45 Satellite Symposium

19:30 - 20:30 Welcome reception & poster session

Day 2, Friday, January 31

08:30 - 10:00 Latest clinical & pre-clinical data

  • ROR1 in CLL / lymphoma / breast cancer
    D Maloney (United States)
  • Novel CAR targets for MM
    N Hosen (Japan) 
  • CD123 for AML and CNS tumors
    S Forman (United States)
  • CD30 / TSCM
    J Briones (Spain)

10:00 - 10:30 Keynote Lecture

  • Updates in CAR T cell therapy
    C June (United States)

10:30 - 11:00 Coffee break & Industry theater session

11:00 - 12:00 Best Abstracts & Flash Talks - Part II

12:00 - 12:30 Keynote lecture

  • Current CAR T Trial activities in China
    JX Wang (China)

12:30 - 14:00 Lunch break

13:15 - 14:00 Satellite Symposium

14:00 - 14:30 Keynote lecture

  • M Sadelain (United States)

14:30 - 16:00 CAR Effector Cells

  • CAR Effector Cells
    K Rezvani (United States)
  • Allogeneic CAR T cells
    W Qasim (United Kingdom)
  • iPS CARs
    M Themeli (the Netherlands)
  • CAR-NK cells as off-the-shelf therapeutics bridging innate and adaptive immunity
    W Wels (Germany)

16:00 - 17:00 Optimizing CAR T treatment

  • Microbiome
    M van den Brink (United States)
  • Visualizing CAR T-cells at work
    J Huppa (Austria)
  • Improving CART-cells in solid tumors
    S Guedan (Spain)

17:00 - 17:30 Coffee break & Industry theater session

17:30 - 19:00 CAR T regulatory session

19:00 - 19:45 Satellite Symposium

Day 3, Saturday, February 1

Detailed Programs of the Nurses, Data managers and Physician tracks to be announced at a later stage

08:30 - 09:45 European Grants/Projects

08:30 - 09:45 Nurses Session

08:30 - 09:45 Data Management Session

09:45 - 10:15 Coffee break & Industry theater session

10:15 - 12:00 Management of side effects (Round table discussion)

10:15 - 12:00 Nurses Session

10:15 - 12:00 Data Management Session

12:00 - 13:00 Lunch Break

12:15 - 13:00 Satellite Symposium

13:00 - 14:30 Implementation of CAR-T Cells in the real world (Round table discussion)

13:00 - 14:30 Nurses Session

14:30 - 15:00 Coffee break & Industry theater session

15:00 - 16:30 Manufacturing of CAR T cell and supply chain management

15:00 - 16:30 Nurses Session

16:30 - 16:45 Closing Remarks

  • H Einsele & C Chabannon (Chairs of the Scientific Program Committee)